Penserra Capital Management LLC Syros Pharmaceuticals, Inc. Transaction History

Penserra Capital Management LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 15, 2022	SELL	$3.26 - $4.66 $4,612 - $6,593	-1,415 Closed	0 $0
Q3 2021 Nov 15, 2021	BUY	$4.08 - $5.66 $20 - $28	5 Added 0.35%	1,415 $6,000
Q2 2021 Aug 12, 2021	BUY	$5.01 - $7.48 $75 - $112	15 Added 1.08%	1,410 $7,000
Q1 2021 May 13, 2021	BUY	$7.19 - $14.95 $2,480 - $5,157	345 Added 32.86%	1,395 $10,000
Q4 2020 Feb 12, 2021	BUY	$6.66 - $14.66 $4,395 - $9,675	660 Added 169.23%	1,050 $11,000
Q3 2020 Nov 13, 2020	BUY	$8.69 - $14.47 $3,389 - $5,643	390 New	390 $3,000

Ticker SYRS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 20,236,200
Market Cap $43.1M
Description
Syros Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development of treatments for cancer and monogenic diseases, and building a pipeline of gene control medicines. The company's lead product candidates are Tamibarotene, a selective retinoic acid receptor alpha agonist, which is in Phase III clinical trial for genomically def...

Get notified when there are updates to the investment portfolio of Penserra Capital Management LLC, based on Form 13F filings with the SEC.

Stay updated on Penserra Capital Management LLC with notifications on news.